neurocare is pleased to announce that it has received FDA clearance for its industry-leading intermittent Theta Burst Stimulation (iTBS) protocol, available across its Apollo TMS Therapy System and other Transcranial Magnetic Stimulation systems for clinical practice.
Read MoreThe newly approved connected device will facilitate patient access and communication between patients and eye care providers, collect data, and provide a platform between home and office to optimize treatment for dry eye
Read More